Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Brain Research

Volumn 1628, Issue , 2015, Pages 298-316

  Qosa, Hisham ^a   Miller, David S ^b   Pasinelli, Piera ^a   Trotti, Davide ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Laboratory of Signal Transduction   (United States)

Author keywords

ABC efflux transporters; Blood brain barrier; Neuroprotection; Pharmacoresistance

Indexed keywords

ABC TRANSPORTER; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; BREAST CANCER RESISTANCE PROTEIN; CATENIN; ENDOTHELIN RECEPTOR; GLUTAMIC ACID; GLUTATHIONE; INTERLEUKIN 1; INTERLEUKIN 6; JUNCTIONAL ADHESION MOLECULE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 5; PHOSPHOLIPID; PROSTAGLANDIN; PROTEIN TYROSINE PHOSPHATASE 1B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; XENOBIOTIC AGENT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN ISCHEMIA; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; CREUTZFELDT JAKOB DISEASE; DEPRESSION; DISEASE COURSE; DNA DAMAGE; DOWN REGULATION; ENHANCER REGION; EPILEPSY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION ENCEPHALITIS; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84952639354     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.07.005     Document Type: Review

References (211)

1. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat Rev Neurosci. 7 2006 41 53
2. N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol Dis. 37 2010 13 25
3. N.J. Abbott Blood-brain barrier structure and function and the challenges for CNS drug delivery J Inherit Metab Dis. 36 2013 437 449
4. A.H. Abuznait, and A. Kaddoumi Role of ABC transporters in the pathogenesis of Alzheimer's disease ACS Chem Neurosci 3 2012 820 831
5. A.H. Abuznait, H. Qosa, B.A. Busnena, K.A. El Sayed, and A. Kaddoumi Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies ACS Chem Neurosci 4 2013 973 982
6. S. Agarwal, R. Sane, J.L. Gallardo, J.R. Ohlfest, and W.F. Elmquist Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux J Pharmacol Exp Ther. 334 2010 147 155
7. S. Agarwal, A.M. Hartz, W.F. Elmquist, and B. Bauer Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up Curr Pharm Des 17 2011 2793 2802
8. S.N. Ahmed Epileptic seizures and epilepsy Epilepsia. 46 2005 1701 1702 1700-1; author reply
9. H. Ak, B. Ay, T. Tanriverdi, G.Z. Sanus, M. Is, M. Sar, B. Oz, C. Ozkara, E. Ozyurt, and M. Uzan Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia Seizure 16 2007 493 503
10. S.G. Aller, J. Yu, A. Ward, Y. Weng, S. Chittaboina, R. Zhuo, P.M. Harrell, Y.T. Trinh, Q. Zhang, I.L. Urbatsch, and G. Chang Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding Science 323 2009 1718 1722
11. E. Aronica, J.A. Gorter, G.H. Jansen, C.W. van Veelen, P.C. van Rijen, S. Leenstra, M. Ramkema, G.L. Scheffer, R.J. Scheper, and D. Troost Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors Neuroscience 118 2003 417 429
12. E. Aronica, J.A. Gorter, S. Redeker, E.A. van Vliet, M. Ramkema, G.L. Scheffer, R.J. Scheper, P. van der Valk, S. Leenstra, J.C. Baayen, W.G. Spliet, and D. Troost Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain Epilepsia 46 2005 849 857
13. E. Aronica, S.M. Sisodiya, and J.A. Gorter Cerebral expression of drug transporters in epilepsy Adv Drug Deliv Rev. 64 2012 919 929
14. T. Ashraf, P.T. Ronaldson, Y. Persidsky, and R. Bendayan Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes J Neurosci Res. 89 2011 1773 1782
15. I.L. Aye, and J.A. Keelan Placental ABC transporters, cellular toxicity and stress in pregnancy Chem Biol Interact. 203 2013 456 466
16. P. Ballabh, A. Braun, and M. Nedergaard The blood-brain barrier: an overview: structure, regulation, and clinical implications Neurobiol Dis. 16 2004 1 13
17. S. Barakat, M. Demeule, A. Pilorget, A. Regina, D. Gingras, L.G. Baggetto, and R. Beliveau Modulation of p-glycoprotein function by caveolin-1 phosphorylation J Neurochem. 101 2007 1 8
18. G.N. Barnes, and J.T. Slevin Ionotropic glutamate receptor biology: effect on synaptic connectivity and function in neurological disease Curr Med Chem. 10 2003 2059 2072
19. D.E. Battle Diagnostic and Statistical Manual of Mental Disorders (DSM) Codas 25 2013 191 192
20. B. Bauer, X. Yang, A.M. Hartz, E.R. Olson, R. Zhao, J.C. Kalvass, G.M. Pollack, and D.S. Miller In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation Mol Pharmacol. 70 2006 1212 1219
21. B. Bauer, A.M. Hartz, and D.S. Miller Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier Mol Pharmacol. 71 2007 667 675
22. B. Bauer, A.M. Hartz, A. Pekcec, K. Toellner, D.S. Miller, and H. Potschka Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling Mol Pharmacol. 73 2008 1444 1453
23. I. Becker, K.F. Becker, R. Meyermann, and V. Hollt The multidrug-resistance gene MDR1 is expressed in human glial tumors Acta Neuropathol. 82 1991 516 519
24. D.J. Begley ABC transporters and the blood-brain barrier Current Pharmaceutical Design. 10 2004 1295 1312
25. M.L. Block, X. Wu, Z. Pei, G. Li, T. Wang, L. Qin, B. Wilson, J. Yang, J.S. Hong, and B. Veronesi Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase FASEB J 18 2004 1618 1620
26. C. Brandt, K. Bethmann, A.M. Gastens, and W. Loscher The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy Neurobiol Dis. 24 2006 202 211
27. A. Brenn, M. Grube, G. Jedlitschky, A. Fischer, B. Strohmeier, M. Eiden, M. Keller, M.H. Groschup, and S. Vogelgesang St. John's Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein Brain Pathol. 24 2014 18 24
28. L. Calderon-Garciduenas, W. Reed, R.R. Maronpot, C. Henriquez-Roldan, R. Delgado-Chavez, A. Calderon-Garciduenas, I. Dragustinovis, M. Franco-Lira, M. Aragon-Flores, A.C. Solt, M. Altenburg, R. Torres-Jardon, and J.A. Swenberg Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution Toxicol Pathol. 32 2004 650 658
29. C.R. Campos, C. Schroter, X. Wang, and D.S. Miller ABC transporter function and regulation at the blood-spinal cord barrier J Cereb Blood Flow Metab. 32 2012 1559 1566
30. P. Candela, F. Gosselet, J. Saint-Pol, E. Sevin, M.C. Boucau, E. Boulanger, R. Cecchelli, and L. Fenart Apical-to-basolateral transport of amyloid-beta peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein J Alzheimers Dis. 22 2010 849 859
31. R.E. Cannon, J.C. Peart, B.T. Hawkins, C.R. Campos, and D.S. Miller Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain Proc Natl Acad Sci U S A 109 2012 15930 15935
32. A. Carrano, J.J. Hoozemans, S.M. van der Vies, A.J. Rozemuller, J. van Horssen, and H.E. de Vries Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy Antioxid Redox Signal. 15 2011 1167 1178
33. T.A. Cartwright, C.R. Campos, R.E. Cannon, and D.S. Miller Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers J Cereb Blood Flow Metab. 33 2013 381 388
34. R. Cecchelli, V. Berezowski, S. Lundquist, M. Culot, M. Renftel, M.P. Dehouck, and L. Fenart Modelling of the blood-brain barrier in drug discovery and development Nat Rev Drug Discov. 6 2007 650 661
35. J. Cen, L. Liu, M.S. Li, L. He, L.J. Wang, Y.Q. Liu, M. Liu, and B.S. Ji Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats J Pharm Pharmacol. 65 2013 665 672
36. S. Chakravarty, and M. Herkenham Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines J Neurosci. 25 2005 1788 1796
37. A. Chan, R. Gold, and N. von Ahsen ATP-binding cassette transporters in inflammatory brain disease Curr Pharm Des 17 2011 2803 2807
38. G.N. Chan, R. Patel, C.L. Cummins, and R. Bendayan Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells Antimicrob Agents Chemother. 57 2013 4481 4488
39. X.B. Chang A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1 Cancer Metastasis Rev. 26 2007 15 37
40. Y.H. Choi, and A.M. Yu ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development Curr Pharm Des 20 2014 793 807
41. J.R. Cirrito, R. Deane, A.M. Fagan, M.L. Spinner, M. Parsadanian, M.B. Finn, H. Jiang, J.L. Prior, A. Sagare, K.R. Bales, S.M. Paul, B.V. Zlokovic, D. Piwnica-Worms, and D.M. Holtzman P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model J Clin Invest. 115 2005 3285 3290
42. M. Citron Alzheimer's disease: strategies for disease modification Nat Rev Drug Discov. 9 2010 387 398
43. S. Dallas, X. Zhu, S. Baruchel, L. Schlichter, and R. Bendayan Functional expression of the multidrug resistance protein 1 in microglia J Pharmacol Exp Ther. 307 2003 282 290
44. S. Dallas, D.S. Miller, and R. Bendayan Multidrug resistance-associated proteins: expression and function in the central nervous system Pharmacol Rev. 58 2006 140 161
45. M. Daood, C. Tsai, M. Ahdab-Barmada, and J.F. Watchko ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS Neuropediatrics 39 2008 211 218
46. S. Dauchy, F. Dutheil, R.J. Weaver, F. Chassoux, C. Daumas-Duport, P.O. Couraud, J.M. Scherrmann, I. De Waziers, and X. Decleves ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier J Neurochem. 107 2008 1518 1528
47. P. Dazert, Y. Suofu, M. Grube, A. Popa-Wagner, H.K. Kroemer, G. Jedlitschky, and C. Kessler Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats Neuroscience 142 2006 1071 1079
48. O.L. de Klerk, A.T. Willemsen, M. Roosink, A.L. Bartels, N.H. Hendrikse, F.J. Bosker, and J.A. den Boer Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier Int J Neuropsychopharmacol. 12 2009 895 904
49. O.L. de Klerk, A.T. Willemsen, F.J. Bosker, A.L. Bartels, N.H. Hendrikse, J.A. den Boer, and R.A. Dierckx Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function Psychiatry Res. 183 2010 151 156
50. X. Decleves, A. Regina, J.L. Laplanche, F. Roux, B. Boval, J.M. Launay, and J.M. Scherrmann Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes J Neurosci Res. 60 2000 594 601
51. X. Decleves, A. Fajac, J. Lehmann-Che, M. Tardy, C. Mercier, I. Hurbain, J.L. Laplanche, J.F. Bernaudin, and J.M. Scherrmann Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines Int J Cancer. 98 2002 173 180
52. J.F. Deeken, and W. Loscher The blood-brain barrier and cancer: transporters, treatment, and Trojan horses Clin Cancer Res. 13 2007 1663 1674
53. N.K. Diop, and C.A. Hrycyna N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane Biochemistry 44 2005 5420 5429
54. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci. 22 1999 391 397
55. T.M. Do, M.S. Noel-Hudson, S. Ribes, C. Besengez, M. Smirnova, S. Cisternino, M. Buyse, F. Calon, G. Chimini, H. Chacun, J.M. Scherrmann, R. Farinotti, and F. Bourasset ABCG2- and ABCG4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood-brain barrier J Alzheimers Dis. 30 2012 155 166
56. D.C. Douek, M. Roederer, and R.A. Koup Emerging concepts in the immunopathogenesis of AIDS Annu Rev Med. 60 2009 471 484
57. E. Driessen, and S.D. Hollon Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators Psychiatr Clin North Am. 33 2010 537 555
58. T. Eisenblatter, S. Huwel, and H.J. Galla Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier Brain Res. 971 2003 221 231
59. A. ElAli, and D.M. Hermann Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain Sci Signal. 3 2010 ra72
60. B.E. Enerson, and L.R. Drewes The rat blood-brain barrier transcriptome J Cereb Blood Flow Metab. 26 2006 959 973
61. R.A. Felix, and M.A. Barrand P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress J Neurochem. 80 2002 64 72
62. N. Ferrara VEGF and the quest for tumour angiogenesis factors Nat Rev Cancer. 2 2002 795 803
63. E.M. Frohman, M.K. Racke, and C.S. Raine Multiple sclerosis - the plaque and its pathogenesis N Engl J Med. 354 2006 942 955
64. D. Fu, and I.M. Arias Intracellular trafficking of P-glycoprotein Int J Biochem Cell Biol. 44 2012 461 464
65. S. Garbuzova-Davis, and P.R. Sanberg Blood-CNS Barrier Impairment in ALS patients versus an animal model Front Cell Neurosci 8 2014 21
66. S. Gazzin, N. Strazielle, C. Schmitt, M. Fevre-Montange, J.D. Ostrow, C. Tiribelli, and J.F. Ghersi-Egea Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces J Comp Neurol. 510 2008 497 507
67. S. Gazzin, A.L. Berengeno, N. Strazielle, F. Fazzari, A. Raseni, J.D. Ostrow, R. Wennberg, J.F. Ghersi-Egea, and C. Tiribelli Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat PLoS One 6 2011 e16165
68. F. Gonzalez-Scarano, and J. Martin-Garcia The neuropathogenesis of AIDS Nat Rev Immunol. 5 2005 69 81
69. C.P. Haar, P. Hebbar, G.C.t. Wallace, A. Das, W.A. Vandergrift 3rd, J.A. Smith, P. Giglio, S.J. Patel, S.K. Ray, and N.L. Banik Drug resistance in glioblastoma: a mini review Neurochem Res. 37 2012 1192 1200
70. M. Haber, J. Smith, S.B. Bordow, C. Flemming, S.L. Cohn, W.B. London, G.M. Marshall, and M.D. Norris Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma J Clin Oncol. 24 2006 1546 1553
71. S. Haga, E. Hinoshita, K. Ikezaki, M. Fukui, G.L. Scheffer, T. Uchiumi, and M. Kuwano Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma Jpn J Cancer Res. 92 2001 211 219
72. A.M. Hartz, B. Bauer, G. Fricker, and D.S. Miller Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1 Mol Pharmacol. 66 2004 387 394
73. A.M. Hartz, B. Bauer, G. Fricker, and D.S. Miller Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide Mol Pharmacol. 69 2006 462 470
74. A.M. Hartz, B. Bauer, M.L. Block, J.S. Hong, and D.S. Miller Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier FASEB J 22 2008 2723 2733
75. A.M. Hartz, E.K. Madole, D.S. Miller, and B. Bauer Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein J Pharmacol Exp Ther. 334 2010 467 476
76. A.M. Hartz, A. Mahringer, D.S. Miller, and B. Bauer 17-beta-Estradiol: a powerful modulator of blood-brain barrier BCRP activity J Cereb Blood Flow Metab. 30 2010 1742 1755
77. A.M. Hartz, D.S. Miller, and B. Bauer Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease Mol Pharmacol. 77 2010 715 723
78. A.M. Hartz, and B. Bauer ABC transporters in the CNS - an inventory Curr Pharm Biotechnol. 12 2011 656 673
79. B.T. Hawkins, and T.P. Davis The blood-brain barrier/neurovascular unit in health and disease Pharmacol Rev. 57 2005 173 185
80. B.T. Hawkins, R.R. Rigor, and D.S. Miller Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay J Cereb Blood Flow Metab. 30 2010 1593 1597
81. B.T. Hawkins, D.B. Sykes, and D.S. Miller Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor J Neurosci. 30 2010 1417 1425
82. K. Hayashi, H. Pu, J. Tian, I.E. Andras, Y.W. Lee, B. Hennig, and M. Toborek HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells J Neurochem. 93 2005 1231 1241
83. K. Hayashi, H. Pu, I.E. Andras, S.Y. Eum, A. Yamauchi, B. Hennig, and M. Toborek HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier J Cereb Blood Flow Metab. 26 2006 1052 1065
84. M.S. Hayden, and S. Ghosh NF-kappaB, the first quarter-century: remarkable progress and outstanding questions Genes Dev. 26 2012 203 234
85. M.T. Heneka, M.J. Carson, J.E. Khoury, G.E. Landreth, F. Brosseron, D.L. Feinstein, A.H. Jacobs, T. Wyss-Coray, J. Vitorica, R.M. Ransohoff, K. Herrup, S.A. Frautschy, B. Finsen, G.C. Brown, A. Verkhratsky, K. Yamanaka, J. Koistinaho, E. Latz, A. Halle, G.C. Petzold, T. Town, D. Morgan, M.L. Shinohara, V.H. Perry, C. Holmes, N.G. Bazan, D.J. Brooks, S. Hunot, B. Joseph, N. Deigendesch, O. Garaschuk, E. Boddeke, C.A. Dinarello, J.C. Breitner, G.M. Cole, D.T. Golenbock, and M.P. Kummer Neuroinflammation in Alzheimer's disease Lancet Neurol. 14 2015 388 405
86. M. Hennessy, and J.P. Spiers A primer on the mechanics of P-glycoprotein the multidrug transporter Pharmacological Research. 55 2007 1 15
87. D.M. Hermann, E. Kilic, A. Spudich, S.D. Kramer, H. Wunderli-Allenspach, and C.L. Bassetti Role of drug efflux carriers in the healthy and diseased brain Ann Neurol. 60 2006 489 498
88. J. Hirrlinger, J. Konig, and R. Dringen Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones J Neurochem. 82 2002 716 719
89. M. Iqbal, H.L. Ho, S. Petropoulos, V.G. Moisiadis, W. Gibb, and S.G. Matthews Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier PLoS One 7 2012 e43022
90. J.W. Ironside, and M.W. Head Biology and neuropathology of prion diseases Handb Clin Neurol 89 2008 779 797
91. M.R. Jablonski, D.A. Jacob, C. Campos, D.S. Miller, N.J. Maragakis, P. Pasinelli, and D. Trotti Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS Neurobiol Dis. 47 2012 194 200
92. M.R. Jablonski, S.S. Markandaiah, D. Jacob, N.J. Meng, K. Li, V. Gennaro, A.C. Lepore, D. Trotti, and P. Pasinelli Inhibiting drug efflux transporters improves efficacy of ALS therapeutics Ann Clin Transl Neurol 1 2014 996 1005
93. J. Jodoin, M. Demeule, L. Fenart, R. Cecchelli, S. Farmer, K.J. Linton, C.F. Higgins, and R. Beliveau P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins J Neurochem. 87 2003 1010 1023
94. L.V. Kalia, and A.E. Lang Parkinson's disease Lancet 2015
95. F.G. Kamar, and J.B. Posner Brain metastases Semin Neurol. 30 2010 217 235
96. J. Kamiie, S. Ohtsuki, R. Iwase, K. Ohmine, Y. Katsukura, K. Yanai, Y. Sekine, Y. Uchida, S. Ito, and T. Terasaki Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria Pharm Res. 25 2008 1469 1483
97. K.D. Kania, H.C. Wijesuriya, S.B. Hladky, and M.A. Barrand Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells Brain Res. 1418 2011 1 11
98. E. Kilic, A. Spudich, U. Kilic, K.M. Rentsch, R. Vig, C.M. Matter, H. Wunderli-Allenspach, J.M. Fritschy, C.L. Bassetti, and D.M. Hermann ABCC1: a gateway for pharmacological compounds to the ischaemic brain Brain 131 2008 2679 2689
99. D.W. Kim, S.K. Lee, K. Chu, I.J. Jang, K.S. Yu, J.Y. Cho, and S.J. Kim Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy Epilepsy Res. 84 2009 86 90
100. J.P. Konsman, S. Vigues, L. Mackerlova, A. Bristow, and A. Blomqvist Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli J Comp Neurol. 472 2004 113 129
101. G. Kooij, J. van Horssen, E.C. de Lange, A. Reijerkerk, S.M. van der Pol, B. van Het Hof, J. Drexhage, A. Vennegoor, J. Killestein, G. Scheffer, R. Oerlemans, R. Scheper, P. van der Valk, C.D. Dijkstra, and H.E. de Vries T lymphocytes impair P-glycoprotein function during neuroinflammation J Autoimmun. 34 2010 416 425
102. G. Kooij, M.R. Mizee, J. van Horssen, A. Reijerkerk, M.E. Witte, J.A. Drexhage, S.M. van der Pol, B. van Het Hof, G. Scheffer, R. Scheper, C.D. Dijkstra, P. van der Valk, and H.E. de Vries Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis Brain 134 2011 555 570
103. R. Kortekaas, K.L. Leenders, J.C. van Oostrom, W. Vaalburg, J. Bart, A.T. Willemsen, and N.H. Hendrikse Blood-brain barrier dysfunction in parkinsonian midbrain in vivo Ann Neurol. 57 2005 176 179
104. I. Kotsopoulos, M. de Krom, F. Kessels, J. Lodder, J. Troost, M. Twellaar, T. van Merode, and A. Knottnerus Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures Seizure 14 2005 175 182
105. M. Krohn, C. Lange, J. Hofrichter, K. Scheffler, J. Stenzel, J. Steffen, T. Schumacher, T. Bruning, A.S. Plath, F. Alfen, A. Schmidt, F. Winter, K. Rateitschak, A. Wree, J. Gsponer, L.C. Walker, and J. Pahnke Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice J Clin Invest. 121 2011 3924 3931
106. G.D. Kruh, and M.G. Belinsky The MRP family of drug efflux pumps Oncogene 22 2003 7537 7552
107. D. Kuhnke, G. Jedlitschky, M. Grube, M. Krohn, M. Jucker, I. Mosyagin, I. Cascorbi, L.C. Walker, H.K. Kroemer, R.W. Warzok, and S. Vogelgesang MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides - implications for the mechanisms of Abeta clearance at the blood-brain barrier Brain Pathol. 17 2007 347 353
108. A. Lazarowski, L. Czornyj, F. Lubienieki, E. Girardi, S. Vazquez, and C. D'Giano ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy Epilepsia 48 Suppl 5 2007 140 149
109. S. Ledoux, R. Yang, G. Friedlander, and D. Laouari Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response Cancer Res. 63 2003 7284 7290
110. G. Lee, K. Babakhanian, M. Ramaswamy, A. Prat, K. Wosik, and R. Bendayan Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems Pharm Res. 24 2007 1262 1274
111. E.M. Leslie, R.G. Deeley, and S.P. Cole Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense Toxicol Appl Pharmacol. 204 2005 216 237
112. C. Li, and R.M. Jackson Reactive species mechanisms of cellular hypoxia-reoxygenation injury Am J Physiol Cell Physiol 282 2002 C227 C241
113. F. Lin, M.C. de Gooijer, E.M. Roig, L.C. Buil, S.M. Christner, J.H. Beumer, T. Wurdinger, J.H. Beijnen, and O. van Tellingen ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy Clin Cancer Res. 20 2014 2703 2713
114. X. Liu, T. Ma, B. Qu, Y. Ji, and Z. Liu Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis Genet Test Mol Biomarkers 17 2013 826 832
115. W. Loscher, and H. Potschka Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases Prog Neurobiol. 76 2005 22 76
116. W. Loscher, and H. Potschka Blood-brain barrier active efflux transporters: ATP-binding cassette gene family NeuroRx 2 2005 86 98
117. W. Loscher, and H. Potschka Drug resistance in brain diseases and the role of drug efflux transporters Nat Rev Neurosci. 6 2005 591 602
118. H. Luna-Munguia, J.D. Salvamoser, B. Pascher, T. Pieper, T. Getzinger, M. Kudernatsch, G. Kluger, and H. Potschka Glutamate-mediated upregulation of the multidrug resistance protein 2 in porcine and human brain capillaries J Pharmacol Exp Ther. 352 2015 368 378
119. C. Luna-Tortos, M. Fedrowitz, and W. Loscher Several major antiepileptic drugs are substrates for human P-glycoprotein Neuropharmacology 55 2008 1364 1375
120. A. Mahringer, and G. Fricker BCRP at the blood-brain barrier: genomic regulation by 17beta-estradiol Mol Pharm. 7 2010 1835 1847
121. M. Maliepaard, G.L. Scheffer, I.F. Faneyte, M.A. van Gastelen, A.C. Pijnenborg, A.H. Schinkel, M.J. van De Vijver, R.J. Scheper, and J.H. Schellens Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res. 61 2001 3458 3464
122. Q. Mao, and J.D. Unadkat Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport - an update AAPS J. 17 2015 65 82
123. A. Milane, C. Fernandez, S. Vautier, G. Bensimon, V. Meininger, and R. Farinotti Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier J Neurochem. 103 2007 164 173
124. D.S. Miller, B. Bauer, and A.M. Hartz Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy Pharmacol Rev. 60 2008 196 209
125. D.S. Miller Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier Trends Pharmacol Sci. 31 2010 246 254
126. D.S. Miller ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology Adv Pharmacol. 71 2014 1 24
127. D.S. Miller Regulation of ABC transporters at the blood-brain barrier Clin Pharmacol Ther. 97 2015 395 403
128. K. Moitra, and M. Dean Evolution of ABC transporters by gene duplication and their role in human disease Biol Chem. 392 2011 29 37
129. S. Nadeau, and S. Rivest Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier Neuroscience 93 1999 1449 1464
130. V.S. Narang, C. Fraga, N. Kumar, J. Shen, S. Throm, C.F. Stewart, and C.M. Waters Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier Am J Physiol Cell Physiol 295 2008 C440 C450
131. A. Nel Atmosphere. Air pollution-related illness: effects of particles Science 308 2005 804 806
132. M.D. Nguyen, J.P. Julien, and S. Rivest Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3 2002 216 227
133. A.T. Nies, G. Jedlitschky, J. Konig, C. Herold-Mende, H.H. Steiner, H.P. Schmitt, and D. Keppler Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain Neuroscience 129 2004 349 360
134. N. Novac, and T. Heinzel Nuclear receptors: overview and classification Curr Drug Targets Inflamm Allergy 3 2004 335 346
135. O.M. Nwaozuzu, L.A. Sellers, and M.A. Barrand Signalling pathways influencing basal and H(2)O(2)-induced P-glycoprotein expression in endothelial cells derived from the blood-brain barrier J Neurochem. 87 2003 1043 1051
136. J.M. Olefsky Nuclear receptor minireview series J Biol Chem. 276 2001 36863 36864
137. R.P. Oude Elferink, and R. de Waart Transporters in the intestine limiting drug and toxin absorption J Physiol Biochem. 63 2007 75 81
138. R. Park, S.Y. Kook, J.C. Park, and I. Mook-Jung Abeta1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-kappaB signaling Cell Death Dis 5 2014 e1299
139. K.E. Parrish, J.N. Sarkaria, and W.F. Elmquist Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier Clin Pharmacol Ther. 97 2015 336 346
140. P. Patak, and D.M. Hermann ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke Curr Pharm Des 17 2011 2787 2792
141. P. Patak, F. Jin, S.T. Schafer, E. Metzen, and D.M. Hermann The ATP-binding cassette transporters ABCB1 and ABCC1 are not regulated by hypoxia in immortalised human brain microvascular endothelial cells Exp Transl Stroke Med 3 2011 12
142. A. Pekcec, B. Unkruer, J. Schlichtiger, J. Soerensen, A.M. Hartz, B. Bauer, E.A. van Vliet, J.A. Gorter, and H. Potschka Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation J Pharmacol Exp Ther. 330 2009 939 947
143. P. Perego, L. Gatti, and G.L. Beretta The ABC of glycosylation Nat Rev Cancer. 10 2010 523
144. A. Pilorget, M. Demeule, S. Barakat, J. Marvaldi, J. Luis, and R. Beliveau Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells J Neurochem. 100 2007 1203 1210
145. M.L. Pinzon-Daza, I.C. Salaroglio, J. Kopecka, R. Garzon, P.O. Couraud, D. Ghigo, and C. Riganti The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells J Cereb Blood Flow Metab. 34 2014 1258 1269
146. B. Poller, J. Drewe, S. Krahenbuhl, J. Huwyler, and H. Gutmann Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier Cell Mol Neurobiol. 30 2010 63 70
147. H. Potschka Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies? Epilepsia 51 2010 1333 1347
148. H. Potschka Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach Pharmacol Ther. 125 2010 118 127
149. A.J. Pratt, E.D. Getzoff, and J.J. Perry Amyotrophic lateral sclerosis: update and new developments Degener Neurol Neuromuscul Dis 2012 2012 1 14
150. H. Qosa, A.H. Abuznait, R.A. Hill, and A. Kaddoumi Enhanced brain amyloid-beta clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease J Alzheimers Dis. 31 2012 151 165
151. H. Qosa, B.S. Abuasal, I.A. Romero, B. Weksler, P.O. Couraud, J.N. Keller, and A. Kaddoumi Differences in amyloid-beta clearance across mouse and human blood-brain barrier models: Kinetic analysis and mechanistic modeling Neuropharmacology 79 C 2014 668 678
152. H. Qosa, H. LeVine 3rd, J.N. Keller, and A. Kaddoumi Mixed oligomers and monomeric amyloid-beta disrupts endothelial cells integrity and reduces monomeric amyloid-beta transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model Biochim Biophys Acta. 1842 2014 1806 1815
153. V.V. Rao, J.L. Dahlheimer, M.E. Bardgett, A.Z. Snyder, R.A. Finch, A.C. Sartorelli, and D. Piwnica-Worms Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier Proc Natl Acad Sci U S A 96 1999 3900 3905
154. S. Rapposelli, M. Digiacomo, and A. Balsamo P-gp transporter and its role in neurodegenerative diseases Curr Top Med Chem. 9 2009 209 217
155. A. Regina, M. Demeule, A. Laplante, J. Jodoin, C. Dagenais, F. Berthelet, A. Moghrabi, and R. Beliveau Multidrug resistance in brain tumors: roles of the blood-brain barrier Cancer Metastasis Rev. 20 2001 13 25
156. D. Ribatti, B. Nico, E. Crivellato, and M. Artico Development of the blood-brain barrier: a historical point of view Anat Rec B New Anat 289 2006 3 8
157. R.R. Rigor, B.T. Hawkins, and D.S. Miller Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain J Cereb Blood Flow Metab. 30 2010 1373 1383
158. S. Rivest Molecular insights on the cerebral innate immune system Brain Behav Immun. 17 2003 13 19
159. S.J. Robertson, K.D. Kania, S.B. Hladky, and M.A. Barrand P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation J Neurochem. 111 2009 132 141
160. S.J. Robertson, R. Mokgokong, K.D. Kania, A.S. Guedj, S.B. Hladky, and M.A. Barrand Nitric oxide contributes to hypoxia-reoxygenation-induced P-glycoprotein expression in rat brain endothelial cells Cell Mol Neurobiol. 31 2011 1103 1111
161. K.R. Robillard, T. Hoque, and R. Bendayan Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier J Pharmacol Exp Ther. 340 2012 96 108
162. P.T. Ronaldson, M. Bendayan, D. Gingras, M. Piquette-Miller, and R. Bendayan Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures J Neurochem. 89 2004 788 800
163. P.T. Ronaldson, and R. Bendayan HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein Mol Pharmacol. 70 2006 1087 1098
164. P.T. Ronaldson, and R. Bendayan HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells J Neurochem. 106 2008 1298 1313
165. G.A. Rosenberg Neurological diseases in relation to the blood-brain barrier J Cereb Blood Flow Metab. 32 2012 1139 1151
166. J.D. Salvamoser, J. Avemary, H. Luna-Munguia, B. Pascher, T. Getzinger, T. Pieper, M. Kudernatsch, G. Kluger, and H. Potschka Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries Mol Pharm. 2015
167. S. Schinelli Pharmacology and physiopathology of the brain endothelin system: an overview Curr Med Chem. 13 2006 627 638
168. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol Rev. 81 2001 741 766
169. F.J. Sharom ABC multidrug transporters: structure, function and role in chemoresistance Pharmacogenomics 9 2008 105 127
170. A. Siddiqui, R. Kerb, M.E. Weale, U. Brinkmann, A. Smith, D.B. Goldstein, N.W. Wood, and S.M. Sisodiya Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1 N Engl J Med. 348 2003 1442 1448
171. G.J. Sills, R. Mohanraj, E. Butler, S. McCrindle, L. Collier, E.A. Wilson, and M.J. Brodie Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment Epilepsia 46 2005 643 647
172. S.M. Sisodiya, J. Heffernan, and M.V. Squier Over-expression of P-glycoprotein in malformations of cortical development Neuroreport 10 1999 3437 3441
173. L.M. Tai, A.J. Loughlin, D.K. Male, and I.A. Romero P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta J Cereb Blood Flow Metab. 29 2009 1079 1083
174. N.C. Tan, S.E. Heron, I.E. Scheffer, J.T. Pelekanos, J.M. McMahon, D.F. Vears, J.C. Mulley, and S.F. Berkovic Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy Neurology 63 2004 1090 1092
175. D.M. Tishler, K.I. Weinberg, D.R. Hinton, N. Barbaro, G.M. Annett, and C. Raffel MDR1 gene expression in brain of patients with medically intractable epilepsy Epilepsia 36 1995 1 6
176. K. Toth, M.M. Vaughan, N.S. Peress, H.K. Slocum, and Y.M. Rustum MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors Am J Pathol. 149 1996 853 858
177. T. Truelsen, and R. Bonita The worldwide burden of stroke: current status and future projections Handb Clin Neurol 92 2009 327 336
178. M. Ueno, T. Nakagawa, C.L. Huang, M. Ueki, T. Kusaka, N. Hosomi, K. Kanenishi, M. Onodera, B. Wu, and H. Sakamoto The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model Neuropathol Appl Neurobiol. 35 2009 147 155
179. D.M. van Assema, M. Lubberink, M. Bauer, W.M. van der Flier, R.C. Schuit, A.D. Windhorst, E.F. Comans, N.J. Hoetjes, N. Tolboom, O. Langer, M. Muller, P. Scheltens, A.A. Lammertsma, and B.N. van Berckel Blood-brain barrier P-glycoprotein function in Alzheimer's disease Brain 135 2012 181 189
180. J. van Os, and S. Kapur Schizophrenia Lancet 374 2009 635 645
181. E.A. van Vliet, R. van Schaik, P.M. Edelbroek, S. Redeker, E. Aronica, W.J. Wadman, N. Marchi, A. Vezzani, and J.A. Gorter Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats Epilepsia 47 2006 672 680
182. E.A. van Vliet, G. Zibell, A. Pekcec, J. Schlichtiger, P.M. Edelbroek, L. Holtman, E. Aronica, J.A. Gorter, and H. Potschka COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats Neuropharmacology 58 2010 404 412
183. V. Vasiliou, K. Vasiliou, and D.W. Nebert Human ATP-binding cassette (ABC) transporter family Hum Genomics 3 2009 281 290
184. S. Vogelgesang, I. Cascorbi, E. Schroeder, J. Pahnke, H.K. Kroemer, W. Siegmund, C. Kunert-Keil, L.C. Walker, and R.W. Warzok Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans Pharmacogenetics 12 2002 535 541
185. S. Vogelgesang, M. Glatzel, L.C. Walker, H.K. Kroemer, A. Aguzzi, and R.W. Warzok Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease Acta Neuropathol. 111 2006 436 443
186. H. Volk, H. Potschka, and W. Loscher Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables J Histochem Cytochem. 53 2005 517 531
187. M. von Wedel-Parlow, P. Wolte, and H.J. Galla Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro J Neurochem. 111 2009 111 118
188. T. Wang, S. Agarwal, and W.F. Elmquist Brain distribution of cediranib is limited by active efflux at the blood-brain barrier J Pharmacol Exp Ther. 341 2012 386 395
189. X. Wang, D.B. Sykes, and D.S. Miller Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier Mol Pharmacol. 78 2010 376 383
190. X. Wang, B.T. Hawkins, and D.S. Miller Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier FASEB J 25 2011 644 652
191. X. Wang, B.T. Hawkins, and D.S. Miller Activating PKC-beta1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS J Cereb Blood Flow Metab. 31 2011 1371 1375
192. X. Wang, C.R. Campos, J.C. Peart, L.K. Smith, J.L. Boni, R.E. Cannon, and D.S. Miller Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers J Neurosci. 34 2014 8585 8593
193. N. Weiss, F. Miller, S. Cazaubon, and P.O. Couraud The blood-brain barrier in brain homeostasis and neurological diseases Biochim Biophys Acta. 1788 2009 842 857
194. G.A. Wellenius, J. Schwartz, and M.A. Mittleman Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries Stroke 36 2005 2549 2553
195. M. Westerlund, A.C. Belin, L. Olson, and D. Galter Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients Cell Tissue Res. 334 2008 179 185
196. H.C. Wijesuriya, J.Y. Bullock, R.L. Faull, S.B. Hladky, and M.A. Barrand ABC efflux transporters in brain vasculature of Alzheimer's subjects Brain Res. 1358 2010 228 238
197. A. Wolf, B. Bauer, and A.M. Hartz ABC Transporters and the Alzheimer's Disease Enigma Front Psychiatry 3 2012 54
198. A.D. Wong, M. Ye, A.F. Levy, J.D. Rothstein, D.E. Bergles, and P.C. Searson The blood-brain barrier: an engineering perspective Front Neuroeng 6 2013 7
199. H. Xiong, D. Callaghan, A. Jones, J. Bai, I. Rasquinha, C. Smith, K. Pei, D. Walker, L.F. Lue, D. Stanimirovic, and W. Zhang ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides J Neurosci. 29 2009 5463 5475
200. G. You, and M.E. Morris Overview of Drug Transporter Families. In Drug Transporters: Molecular Characterization and Role in Drug Disposition 2006 John Wiley & Sons, Inc. 1 10 Vol., ed.eds
201. S. Yousif, C. Marie-Claire, F. Roux, J.M. Scherrmann, and X. Decleves Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy Brain Res. 1134 2007 1 11
202. S. Yousif, C. Chaves, S. Potin, I. Margaill, J.M. Scherrmann, and X. Decleves Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation J Neurochem. 123 2012 491 503
203. J.A. Zastre, G.N. Chan, P.T. Ronaldson, M. Ramaswamy, P.O. Couraud, I.A. Romero, B. Weksler, M. Bendayan, and R. Bendayan Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line J Neurosci Res. 87 2009 1023 1036
204. N.C. Zembruski, G. Buchel, L. Jodicke, M. Herzog, W.E. Haefeli, and J. Weiss Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro J Antimicrob Chemother. 66 2011 802 812
205. W. Zhang, J. Mojsilovic-Petrovic, M.F. Andrade, H. Zhang, M. Ball, and D.B. Stanimirovic The expression and functional characterization of ABCG2 in brain endothelial cells and vessels FASEB J 17 2003 2085 2087
206. Y.L. Zhao, J. Du, H. Kanazawa, X.B. Cen, K. Takagi, K. Kitaichi, Y. Tatsumi, M. Ohta, and T. Hasegawa Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice Brain Res. 956 2002 246 253
207. S.F. Zhou, L.L. Wang, Y.M. Di, C.C. Xue, W. Duan, C.G. Li, and Y. Li Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development Curr Med Chem. 15 2008 1981 2039
208. H.J. Zhu, and G.Q. Liu Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism Life Sci. 75 2004 1313 1322
209. G. Zibell, B. Unkruer, A. Pekcec, A.M. Hartz, B. Bauer, D.S. Miller, and H. Potschka Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition Neuropharmacology 56 2009 849 855
210. B.V. Zlokovic The blood-brain barrier in health and chronic neurodegenerative disorders Neuron 57 2008 178 201
211. K. Zschiedrich, I.R. Konig, N. Bruggemann, N. Kock, M. Kasten, K.L. Leenders, V. Kostic, P. Vieregge, A. Ziegler, C. Klein, and K. Lohmann MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? J Neurol 256 2009 115 120